Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...

Obesity is now one of the biggest health problems in the world. According to the World Health Organization (WHO), over 1 ...

Low-dose semaglutide (Ozempic, Wegovy) improved glycemic control and weight outcomes in a randomized trial of adults whose ...

Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of managing cardio-renal-metabolic disease.

In this week’s edition of InnovationRx, we look at the Forbes 30 Under 30 Healthcare list, the coming barriers to getting ...

The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...

Dr. Patrick Pagador at Seriously Health joined us with information about GLP-1’s and how they help patients lose weight.

Negotiations that could have led to coverage for weight-loss drug Wegovy under Canadian public health plans are not moving ...

Some states are rethinking their coverage of GLP-1 drugs for weight loss as budgets tighten and Medicaid programs brace for ...

Women with obesity who discontinued GLP-1s were at increased risk for multiple adverse pregnancy outcomes than those who had ...

Obesity isn’t just a human problem; around 60% of cats and dogs in the U.S. are considered overweight or obese. Now, a new ...

Experts unpack the implications of CBER Director Vinay Prasad’s claim that COVID vaccines have caused 10+ child deaths; the ...